郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价Direct evidence for high affinity blockade of NaV1.6 channel subtype by huwentoxin-IV spider peptide, using multiscale functional approaches.

期刊:Neuropharmacology发表年份:2018作者:Tânia C Gonçalves; Rachid Boukaiba; Jordi Molgó; Muriel Amar; Michel Partiseti; Denis Servent; Evelyne Benoit

药效评价In vitro and in vivo characterization of the bifunctional μ and δ opioid receptor ligand UFP-505.

期刊:British journal of pharmacology发表年份:2018作者:N Dietis; H Niwa; R Tose; J McDonald; V Ruggieri; M Filaferro; G Vitale; L Micheli; C Ghelardini; S Salvadori; G Calo; R Guerrini; D J Rowbotham; D G Lambert

药效评价Synthesis, Pharmacological Evaluation, and Docking Studies of Novel Pyridazinone-Based Cannabinoid Receptor Type 2 Ligands.

期刊:ChemMedChem发表年份:2018作者:Giulio Ragusa; Serena Bencivenni; Paula Morales; Tyra Callaway; Dow P Hurst; Battistina Asproni; Stefania Merighi; Giovanni Loriga; Gerard A Pinna; Patricia H Reggio; Stefania Gessi; Gabriele Murineddu

药效评价1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1) as a Model for the Rational Design of a Novel Class of Brain Penetrant Ligands with High Affinity and Selectivity for Dopamine D4 Receptor.

期刊:Journal of medicinal chemistry发表年份:2018作者:Fabio Del Bello; Alessandro Bonifazi; Gianfabio Giorgioni; Carlo Cifani; Maria Vittoria Micioni Di Bonaventura; Riccardo Petrelli; Alessandro Piergentili; Stefano Fontana; Valerio Mammoli; Hideaki Yano; Rosanna Matucci; Giulio Vistoli; Wilma Quaglia